By specifically inhibiting NF-κB-dependent MMP-9 (matrix metalloproteinase-9) gene expression, delphinidin can function as a potential antimetastatic drug that inhibits PMA-induced cancer cell invasion [38]. This evidence concerns the gene NFKB1 and cancer.